Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104892623B enables high-purity 5-ISMN production. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier solutions.
Patent CN117003642A reveals a novel route for Ensitrelvir intermediates. Achieve high purity and reduced costs with scalable pharmaceutical intermediate manufacturing strategies.
Patent CN104892623A reveals high-purity Isosorbide 5-mononitrate synthesis. Enhanced selectivity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102633802B details a scalable 3-step route for 2-chloro-7H-pyrrolo[2,3-d]pyrimidine, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN101056853B reveals a novel Pd-catalyzed regioselective hydrogenation route for isoindole derivatives, offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN109593045B details a green oxidative condensation route for 11-aminoundecanoic acid, offering cost reduction in polyamide manufacturing and scalable supply.
Patent CN115636776A details a novel Alprostadil synthesis using PGF2α waste. This green method offers significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Patent CN107141325A reveals novel astilbin derivatives improving bioavailability. Reliable supplier for scalable pharmaceutical intermediates manufacturing.
Solve supply chain risks and low yields in anticancer intermediate production. Discover a 4-step, 84% yield route using common raw materials. Contact us for scalable CDMO solutions.
Eliminate high-pressure hydrogenation and resolution steps in Moxifloxacin side chain production. Achieve 99%+ ee and 20-30% yield with simplified process. Reduce costs and supply chain risks for API manufacturing.